Combined liraglutide and metformin therapy in overweight or obese women with polycystic ovary syndrome: A systematic review and meta‐analysis

Ähnliche Einträge

• Metformin use in women with polycystic ovary syndrome ( PCOS ): Opportunities, benefits, and clinical challenges
  von: Saeede Saadati, et al.
  Veröffentlicht: (2025)
• Adherence to liraglutide among individuals with overweight and obesity: Patient characteristics and clinical measures
  von: Amit Guy, et al.
  Veröffentlicht: (2024)
• Cannabidiol improves metabolic profiles and alleviates liver inflammation and fibrosis in conditions of androgenic obesity and polycystic ovary syndrome
  von: Francisco J. Ponce‐Díaz, et al.
  Veröffentlicht: (2025)
• Does metformin reduce the risk of cancer in obesity and diabetes? A systematic review and meta‐analysis
  von: Leonardo A. Mesquita, et al.
  Veröffentlicht: (2024)
• The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta‐analysis of randomized controlled trials
  von: Rachelle Haber, et al.
  Veröffentlicht: (2024)